30 results
8-K
VIR
Vir Biotechnology Inc
13 Dec 23
Cost Associated with Exit or Disposal Activities
4:06pm
are designed to optimize the Company’s cost structure by reducing the size of its workforce and the number of sites it operates in. The Company … of its innate immunity small molecule group initiated in the third quarter of 2023, will represent approximately 12% of the workforce or 75 positions
8-K
EX-99.2
2g2i6
6 Jul 20
Our mission is to create a world without infectious disease
6:32am